Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial

被引:35
|
作者
Ried-Larsen, Mathias [1 ,2 ]
Johansen, Mette Y. [1 ,2 ]
MacDonald, Christopher S. [1 ,2 ,3 ]
Hansen, Katrine B. [1 ,2 ]
Christensen, Robin [4 ,5 ]
Wedell-Neergaard, Anne-Sophie [1 ,2 ]
Pilmark, Nanna Skytt [1 ,2 ]
Langberg, Henning [3 ]
Vaag, Allan A. [6 ]
Pedersen, Bente K. [1 ,2 ]
Karstoft, Kristian [1 ,2 ,7 ]
机构
[1] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark
[2] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, CopenRehab,Sect Social Med, Copenhagen, Denmark
[4] Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark
[5] Univ Southern Denmark, Odense Univ Hosp, Dept Clin Res, Res Unit Rheumatol, Odense, Denmark
[6] AstraZeneca, IMED Biotech Unit, Early Clin Dev, Cardiovasc & Metab Dis Translat Med Unit, Gothenburg, Sweden
[7] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark
来源
DIABETES OBESITY & METABOLISM | 2019年 / 21卷 / 10期
关键词
clinical trial; dietary intervention; exercise intervention; type; 2; diabetes; weight control; Y GASTRIC BYPASS; LAPAROSCOPIC SLEEVE GASTRECTOMY; GLYCEMIC CONTROL; MORBID-OBESITY; WEIGHT-LOSS; METAANALYSIS; MELLITUS; OUTCOMES; SURGERY; DIET;
D O I
10.1111/dom.13802
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To investigate whether an intensive lifestyle intervention induces partial or complete type 2 diabetes (T2D) remission. Materials and methods In a secondary analysis of a randomized, assessor-blinded, single-centre trial, people with non-insulin-dependent T2D (duration <10 years), were randomly assigned (2:1, stratified by sex, from April 2015 to August 2016) to a lifestyle intervention group (n = 64) or a standard care group (n = 34). The primary outcome was partial or complete T2D remission, defined as non-diabetic glycaemia with no glucose-lowering medication at the outcome assessments at both 12 and 24 months from baseline. All participants received standard care, with standardized, blinded, target-driven medical therapy during the initial 12 months. The lifestyle intervention included 5- to 6-weekly aerobic and combined aerobic and strength training sessions (30-60 minutes) and individual dietary plans aiming for body mass index <= 25 kg/m(2). No intervention was provided during the 12-month follow-up period. Results Of the 98 randomized participants, 93 completed follow-up (mean [SD] age 54.6 [8.9] years; 46 women [43%], mean [SD] baseline glycated haemoglobin 49.3 [9.3] mmol/mol). At follow-up, 23% of participants (n = 14) in the intervention and 7% (n = 2) in the standard care group met the criteria for any T2D remission (odds ratio [OR] 4.4, 95% confidence interval [CI] 0.8-21.4]; P = 0.08). Assuming participants lost to follow-up (n = 5) had relapsed, the OR for T2D remission was 4.4 (95% CI 1.0-19.8; P = 0.048). Conclusions The statistically nonsignificant threefold increased remission rate of T2D in the lifestyle intervention group calls for further large-scale studies to understand how to implement sustainable lifestyle interventions among people with T2D.
引用
收藏
页码:2257 / 2266
页数:10
相关论文
共 50 条
  • [31] Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial
    M. Trento
    P. Passera
    M. Bajardi
    M. Tomalino
    G. Grassi
    E. Borgo
    C. Donnola
    F. Cavallo
    P. Bondonio
    M. Porta
    Diabetologia, 2002, 45 : 1231 - 1239
  • [32] Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus
    Hocking, Samantha L.
    Markovic, Tania P.
    Lee, Crystal M. Y.
    Picone, Tegan J.
    Gudorf, Kate E.
    Colagiuri, Stephen
    DIABETES CARE, 2024, 47 (01) : 66 - 70
  • [33] Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)
    Thom, G.
    Messow, C. -M.
    Leslie, W. S.
    Barnes, A. C.
    Brosnahan, N.
    McCombie, L.
    Al-Mrabeh, A.
    Zhyzhneuskaya, S.
    Welsh, P.
    Sattar, N.
    Taylor, R.
    Lean, M. E. J.
    DIABETIC MEDICINE, 2021, 38 (08)
  • [34] Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)
    Thom, G.
    Messow, C. M.
    Leslie, W. S.
    McCombie, L.
    Brosnahan, N.
    Barnes, A. C.
    Sattar, N.
    Taylor, R.
    Lean, M. E. J.
    DIABETIC MEDICINE, 2020, 37 : 179 - 180
  • [35] Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial
    Mcinnes, Natalia
    Hall, Stephanie
    Lochnan, Heather A.
    Harris, Stewart B.
    Punthakee, Zubin
    Sigal, Ronald J.
    Hramiak, Irene
    Azharuddin, Mohammed
    Liutkus, Joanne F.
    Yale, Jean-Francois
    Sultan, Farah
    Smith, Ada C.
    Otto, Rose E.
    Sherifali, Diana
    Liu, Yan Yun
    Gerstein, Hertzel C.
    DIABETES, 2021, 70
  • [36] One-year effects of a group-based lifestyle intervention in adults with type 2 diabetes: A randomized encouragement trial
    Liss, David T.
    Finch, Emily A.
    Cooper, Andrew
    Sheth, Avani
    Tejuosho, Ashanti D.
    Lancki, Nicola
    Ackermann, Ronald T.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 140 : 36 - 44
  • [37] Total Diet Replacement Within an Integrated Intensive Lifestyle Intervention for Remission of Type 2 Diabetes: Lessons From DiRECT
    Noronha, Jarvis C.
    Thom, George
    Lean, Michael E. J.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] Mobile Health Intervention in Patients With Type 2 Diabetes A Randomized Clinical Trial
    Gerber, Ben S.
    Biggers, Alana
    Tilton, Jessica J.
    Marsh, Daphne E. Smith
    Lane, Rachel
    Mihailescu, Dan
    Lee, Jungae
    Sharp, Lisa K.
    JAMA NETWORK OPEN, 2023, 6 (09) : E2333629
  • [39] Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 Diabetes Feasibility and 1-Year Results of a Randomized Clinical Trial
    Halperin, Florencia
    Ding, Su-Ann
    Simonson, Donald C.
    Panosian, Jennifer
    Goebel-Fabbri, Ann
    Wewalka, Marlene
    Hamdy, Osama
    Abrahamson, Martin
    Clancy, Kerri
    Foster, Kathleen
    Lautz, David
    Vernon, Ashley
    Goldfine, Allison B.
    JAMA SURGERY, 2014, 149 (07) : 716 - 726
  • [40] Pathophysiology of Remission in Type 2 Diabetes-The Diabetes Remission Clinical Trial (DiRECT)
    Taylor, Roy
    Al-Mrabeh, Ahmad
    Zhyzhneuskaya, Sviatlana V.
    Peters, Carl
    Barnes, Alison C.
    Aribisala, Benjamin
    Hollingsworth, Kieren G.
    Sattar, Naveed
    Lean, Michael E.
    DIABETES, 2019, 68